Henry Schein
Henry Schein, Inc. (Nasdaq: HSIC) distributes health care products and services primarily to office-based dental and medical practitioners and alternate care sites, including dental practices, laboratories, physician practices, ambulatory surgery centers, home health providers, and government and institutional… From the company’s description.
In fiscal 2025, Henry Schein reported revenue of $13.18B, up 4.0% from fiscal 2024, and net income of $419.00M. Its operating margin was 5.0%, and operations generated $712.00M in cash. Over the twelve months to Jun 27, 2026, revenue was $13.60B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Henry Schein does
In the company’s own words
Henry Schein, Inc. (Nasdaq: HSIC) distributes health care products and services primarily to office-based dental and medical practitioners and alternate care sites, including dental practices, laboratories, physician practices, ambulatory surgery centers, home health providers, and government and institutional clinics. Its offerings include dental and medical supplies, equipment, pharmaceuticals, vaccines, practice services, financing solutions, and software. The company operates through three reportable segments: Global Distribution and Value-Added Services, which accounted for 84.5% of fiscal 2025 net sales; Global Specialty Products, 11.7%; and Global Technology, 5.1%, with the balance eliminated between segments. Specialty products include dental implants, biomaterials, orthodontic and endodontic products, and orthopedic devices; technology offerings include practice management, clinical workflow, analytics, and patient engagement software. Henry Schein serves more than one million customers worldwide and employs more than 25,000 people. Its software brands include Dentrix, Dentally, AxiUm, and Demandforce. Its website is https://www.henryschein.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Wholesale
- Headquarters
- MELVILLE, NY
- Fiscal year end
- December
- CIK
- 1000228
- SIC
- 5047
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Henry Schein — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Henry Schein · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Henry Schein’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Henry Schein and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Henry Schein's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Henry Schein's last four quarterly filings that the numbers alone won't show?”